Detalles de la búsqueda
1.
Iniparib administered weekly or twice-weekly in combination with gemcitabine/carboplatin in patients with metastatic triple-negative breast cancer: a phase II randomized open-label study with pharmacokinetics.
Breast Cancer Res Treat
; 177(2): 383-393, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31172407
2.
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.
Breast Cancer Res Treat
; 154(2): 351-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26536871
3.
Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas.
J Neurooncol
; 125(1): 123-31, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26285766
4.
Safety, Tolerability, and Pharmacokinetics of TAK-931, a Cell Division Cycle 7 Inhibitor, in Patients with Advanced Solid Tumors: A Phase I First-in-Human Study.
Cancer Res Commun
; 2(11): 1426-1435, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36970056
5.
Gastrointestinal complications in patients treated with ipilimumab and nivolumab combination therapy or monotherapy.
J Comp Eff Res
; 8(2): 81-90, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30547675
6.
Gastrointestinal adverse events with combination of checkpoint inhibitors in advanced melanoma: a systematic review.
Melanoma Manag
; 5(1): MMT01, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30190927
7.
Assessment of the value of confirming responses in clinical trials in oncology.
Eur J Cancer
; 41(11): 1528-32, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16026690
8.
A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD).
Clin Transl Oncol
; 7(11): 493-8, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16373060
9.
Phase III study of iniparib plus gemcitabine and carboplatin versus gemcitabine and carboplatin in patients with metastatic triple-negative breast cancer.
J Clin Oncol
; 32(34): 3840-7, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25349301
10.
Connexin-26 is a key factor mediating gemcitabine bystander effect.
Mol Cancer Ther
; 10(3): 505-17, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21388975
11.
Phase I study of Oral gemcitabine prodrug (LY2334737) alone and in combination with erlotinib in patients with advanced solid tumors.
Clin Cancer Res
; 17(18): 6071-82, 2011 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21753156
12.
The role of extreme phenotype selection studies in the identification of clinically relevant genotypes in cancer research.
Cancer
; 95(7): 1605-10, 2002 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12237932
13.
Phase I pharmacokinetic study of a single intravesical instillation of gemcitabine administered immediately after transurethral resection plus multiple random biopsies in patients with superficial bladder cancer.
J Urol
; 172(2): 485-8, 2004 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-15247710
14.
A phase II trial of gemcitabine and weekly high-dose 5-fluorouracil in a 48-hour continuous-infusion schedule in patients with advanced pancreatic carcinoma. A study of the Spanish Cooperative Group for Gastrointestinal Tumour Therapy (TTD)
Clin. transl. oncol. (Print)
; 7(11): 493-498, dic. 2005. tab, graf
Artículo
en En
| IBECS (España) | ID: ibc-041722
Resultados
1 -
14
de 14
1
Próxima >
>>